Overview
No overview information available.
Indication
No indication information available.
Associated Conditions
No associated conditions information available.
Clinical Trials
Title | Posted | Study ID | Phase | Status | Sponsor |
|---|
No clinical trials found
No clinical trials found for this drug
FDA Drug Approvals
Approved Product | Manufacturer | NDC Code | Route | Strength | Effective Date |
|---|---|---|---|---|---|
| Bracco Diagnostics Inc | 0270-0445 | ORAL, RECTAL | 660 mg in 1 mL | 4/23/2018 | |
| BRACCO DIAGNOSTICS INC | 0270-0149 | INTRAVENOUS | 300 mg in 1 mL | 4/15/2018 | |
| Guardian Drug Company | 53041-688 | ORAL, RECTAL | 660 mg in 1 mL | 12/18/2020 | |
| Liebel-Flarsheim Company LLC | 0019-4816 | ORAL, RECTAL | 600 mg in 1 mL | 2/15/2017 | |
| Camber Pharmaceuticals, Inc. | 31722-019 | ORAL, RECTAL | 660 mg in 1 mL | 12/18/2023 | |
| BRACCO DIAGNOSTICS INC | 0270-1410 | INTRAVESICAL | 180 mg in 1 mL | 10/2/2018 | |
| Guardian Drug Company | 53041-690 | ORAL, RECTAL | 660 mg in 1 mL | 12/18/2020 |
EMA Drug Approvals
Approved Product | Authorization Holder | Status | Issued Date |
|---|---|---|---|
| No EMA approvals found for this drug. | |||
HSA Drug Approvals
Approved Product | Manufacturer | Approval Number | Dosage Form | Strength | Approval Date |
|---|---|---|---|---|---|
| No HSA approvals found for this drug. | |||||
NMPA Drug Approvals
Approved Product | Company | Approval Number | Drug Type | Dosage Form | Approval Date |
|---|---|---|---|---|---|
| No NMPA approvals found for this drug. | |||||
PPB Drug Approvals
Approved Product | Registration No. | Company | Licence No. | Strength | Registration Date |
|---|---|---|---|---|---|
| No PPB approvals found for this drug. | |||||
TGA Drug Approvals
Approved Product | ARTG ID | Sponsor | Registration Type | Status | Registration Date |
|---|---|---|---|---|---|
| No TGA approvals found for this drug. | |||||
Health Canada Drug Approvals
Approved Product | Company | DIN | Dosage Form | Strength | Market Date |
|---|---|---|---|---|---|
| GASTROGRAFIN | 02228564 | Solution - Rectal
,
Oral | 66 % | 12/30/1978 | |
| MD-76 | tyco healthcare | 00569739 | Solution - Intra-Arterial
,
Intravenous | 660 MG / ML | 12/31/1982 |
| SINOGRAFIN | squibb canada inc., division of bristol-myers squibb canada inc. | 00184330 | Liquid - Intrauterine | 52.7 % | 12/31/1966 |
| RENOGRAFIN-60 LIQ | squibb diagnostics, division of bristol-myers squibb canada inc. | 01974009 | Liquid - Intravenous | 52 % | 12/31/1955 |
| RENO-M-DIP LIQ 30% | squibb diagnostics, division of bristol-myers squibb canada inc. | 01973991 | Liquid - Intravenous | 30 % | 12/31/1981 |
| GASTROGRAFIN LIQ | squibb diagnostics, division of bristol-myers squibb canada inc. | 01995669 | Liquid - Refer (See Dosage Form)
,
Oral | 66 % | 12/31/1958 |
| RENO-DIP | 02228572 | Liquid - Intravenous | 30 % | 7/20/1998 | |
| HYPAQUE-M 18% LIQ | sanofi canada, inc. | 02026945 | Liquid - Intravenous
,
Cystography | 18 % | 12/31/1979 |
| HYPAQUE-M LIQ 76% USP | sterling winthrop inc. | 01904841 | Liquid - Intravenous | 66 % | 12/31/1992 |
| RENOCAL-76 | 02232998 | Liquid - Intravenous | 66 % | 7/1/1999 |
CIMA AEMPS Drug Approvals
Approved Product | Company | Registration Number | Pharmaceutical Form | Prescription Type | Status |
|---|---|---|---|---|---|
| No CIMA AEMPS (Spain) approvals found for this drug. | |||||
Philippines FDA Drug Approvals
Approved Product | Company | License Number | Dosage Form | Strength | Approval Date |
|---|---|---|---|---|---|
| No Philippines FDA approvals found for this drug. | |||||
Saudi SFDA Drug Approvals
Approved Product | Company | License Number | Dosage Form | Strength | Approval Date |
|---|---|---|---|---|---|
| No Saudi SFDA approvals found for this drug. | |||||
Malaysia NPRA Drug Approvals
Approved Product | Company | Registration Number | Dosage Form | Strength | Approval Date |
|---|---|---|---|---|---|
| No Malaysia NPRA approvals found for this drug. | |||||
UK EMC Drug Information
Medicine Name | MA Holder | MA Number | Pharmaceutical Form | Active Ingredient | Authorization Date |
|---|---|---|---|---|---|
| No UK EMC drug information found for this drug. | |||||
Help Us Improve
Your feedback helps us provide better drug information and insights.